Navigation Links
Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Date:7/30/2013

CARLSBAD, Calif., July 30, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $2 million milestone payment from GlaxoSmithKline (NYSE: GSK) related to the advancement of the ongoing Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP). 

ISIS-TTRRx is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare genetic disease characterized by progressive dysfunction of peripheral nerve and/or heart tissues.  Isis has earned $20 million in upfront and milestone payments prior to first patient dosed in the ongoing Phase 2/3 study.  The $2 million milestone payment announced today is the first milestone of the $50 million in milestone payments Isis is eligible to earn as the Phase 2/3 study progresses.  In addition, if GSK elects to exercise its option to exclusively license the ISIS-TTRRx program, Isis is eligible to receive a license fee, regulatory and sales milestone payments and double-digit royalties on sales of ISIS-TTRRx.

The Phase 2/3 study of ISIS-TTRRx is a randomized, double-blind, placebo-controlled, international study designed to support an application for marketing approval of ISIS-TTRRx in patients with FAP.  The fifteen month study will measure the effects of ISIS-TTRRx on neurological dysfunction and on quality-of-life.  For further study information, please visit www.clinicaltrials.gov and search for the identifier number NCT01737398.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Trinity Biotech plc (Nasdaq: TRIB ... products for the point-of-care and clinical laboratory markets, ... wholly-owned subsidiary (the "Issuer"), intends to offer, subject ... principal amount of Exchangeable Senior Notes due 2045 ... pursuant to Rule 144A under the Securities Act ...
(Date:4/1/2015)... 2015  Hologic, Inc. (NASDAQ: HOLX ) announced ... Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 ... the trustee, paying agent and conversion agent for the ... This conversion right is subject to the terms of ... December 10, 2007, as supplemented by the second supplemental ...
(Date:4/1/2015)... NORTHBROOK, Ill. and ASPEN, Colo. ... Inc., in partnership with the Chris Klug Foundation (CKF), is ... Nominations are now being accepted for the award, which ... post-transplant quality of life, whether it is a career ... leading a fulfilling life with family and loved ones. ...
Breaking Medicine Technology:Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3
... Reportlinker.com announces that a new market research report ... Reportlinker Adds Pharma 101: An Overview of the ... http://www.reportlinker.com/p0155107/Reportlinker-Adds-Pharma-101-An-Overview-of-the-Life-Sciences-Industry-(Analyst-Insight).html , Introduction , The life ... the proper background, it can be difficult for ...
... 16 Reportlinker.com announces that a ... in its catalogue. , ... Market Outlook To 2014: Policy environment, ... , http://www.reportlinker.com/p0155347/Reportlinker-Adds-The-Middle-Eastern-Pharmaceutical-Market-Outlook-To-2014-Policy-environment-market-structure-competitive-landscape-growth-opportunities.html ...
Cached Medicine Technology:Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight) 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 11
(Date:4/1/2015)... York (PRWEB) April 01, 2015 The ... of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled ... calendar for the Philadelphia Court of Common Pleas, the ... 206, City Hall. Court records indicate that the proceeding ... on behalf of Risperdal users who experienced gynecomastia (male ...
(Date:4/1/2015)... Chicago, IL, Northfield, IL, Bethesda, MD, Alexandria, VA ... American Society for Clinical Pathology (ASCP), the College ... Pathology (AMP), and the American Society of Clinical ... clinical practice guideline on the use of molecular ... colorectal carcinoma. This evidence-based guideline will help establish ...
(Date:4/1/2015)... Dr. Daniel C. Stewart ... to discuss the benefits of the LANAP® treatment over ... periodontal disease. People who live in Howard County, and ... can now visit Dr. Stewart, a Maryland dentist, for ... the LANAP® protocol, which is a laser gum surgery ...
(Date:4/1/2015)... 2015 GrassrootsHealth, an international nonprofit ... medical education (CME) courses about vitamin D ... more confident in measuring, prescribing, and tracking vitamin ... these CME courses, practitioners can apply for D*certification ... available are “Vitamin D, Sunshine, Optimal Health: Putting ...
(Date:4/1/2015)... Miramar, FL (PRWEB) April 01, 2015 ... has received Provisional Certificate of Authority (PCOA) approval from ... important step in the ongoing development of a retirement ... enrich individual health, wellness and spiritual development. , America’s ... prepared to meet the housing needs of seniors, according ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2
... Federal Emergency Management Agency (FEMA) of America is under ... stamped on warnings from its own field workers ... housed in government-provided trailers were exposed to levels of ... U.S. workers. ,A trail of e-mails obtained ...
... Thursday banned artificial trans fat and required nutrition labeling for ... applies to Seattle and most of its suburbs despite objections ... produced when hydrogen is added to vegetable oil, increase the ... been linked to obesity, heart disease and diabetes. ...
... People's Congress deputy has called on the Chinese Government ... commercials, at least during the summer and winter holiday ... been convinced about this after hearing her eight-year-old daughter ... don't like fat girls after watching a TV ad ...
... magazine 'Computing Which?' has compiled a list of 101 ... access to advice on almost every matter ranging from ... ,Although the journal has enlisted websites pertaining ... of the most useful and popular sources, such as ...
... lifetime risk of cancer associated with radiation exposure from ... with the risk greater for women and younger patients, ... models. ,The study, published in the journal ... by Andrew J. Einstein, at the Columbia University College ...
... that mature heart cells can not only replicate, but also ... environment. ,The researchers noted that a sponge-like ... the injury can help heart cells to begin dividing and ... component of the material that surrounds cells and is derived ...
Cached Medicine News:Health News:Katrina Evacuees Made To Remain In Toxic Air 2Health News:Artificial Trans Fat Banned in Chain Restaurant in King County 2Health News:101 Websites That can Change Your Life Enlisted 2Health News:Women, Younger Patients at Greater Lifetime Cancer Risk from CT Scan 2Health News:Scientists Demonstrate Heart Cell Replication in Mice 2
... liquid stable reagent offers the laboratory ... stability to help maximize laboratory productivity, ... result turnaround time. The patented technology ... a long shelf life that will ...
... liquid stable reagent offers the laboratory ... stability to help maximize laboratory productivity, ... result turnaround time. The proprietary technology ... a long shelf life that will ...
... Lithium single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... reagent provides a long shelf life ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
Medicine Products: